readthroughSign in
CompanyTVRDNasdaqSugar Land, TX

Tvardi Therapeutics, Incorporated

Tvardi Therapeutics develops oral small molecule STAT3 inhibitors for inflammatory, proliferative, and cancer diseases.

10-QNov 13Latest SEC filing
Nov 13Latest story